EBNA IgG Rapid Test

Rapid detection of Epstein-Barr virus (EBV) antibodies can help support the investigation of EBV infection. Biopanda offers EBNA IgG Rapid Tests for the qualitative detection of IgG antibodies associated with Epstein-Barr virus, providing convenient rapid testing options for healthcare professionals and clinical laboratories. The range includes a dedicated EBNA IgG Rapid Test and a combination test for the simultaneous detection of EBV Viral Capsid Antigen (VCA) IgG and Epstein-Barr Nuclear Antigen (EBNA) IgG antibodies, enabling different EBV antibody markers to be assessed according to testing requirements.

Why Test for EBV EBNA IgG Antibodies?

Epstein-Barr virus (EBV) is a common human herpesvirus and the primary cause of infectious mononucleosis. EBV infection can produce symptoms including fever, sore throat, swollen lymph nodes and fatigue, although the clinical presentation can vary and infection may also be asymptomatic.

Following EBV infection, the immune system produces antibodies against different viral antigens. Epstein-Barr Nuclear Antigen (EBNA) IgG antibodies are one of the antibody markers that can be assessed as part of EBV serological testing.

Testing different EBV antibodies can help provide information about an individual's antibody profile. EBNA IgG and Viral Capsid Antigen (VCA) IgG testing may be used alongside other appropriate EBV markers, clinical findings and diagnostic procedures when investigating suspected or previous Epstein-Barr virus infection.

Biopanda offers rapid testing options for EBNA IgG antibodies, including a dedicated EBNA IgG test and a combined EBV VCA IgG and EBNA IgG Rapid Test, providing healthcare professionals and clinical laboratories with convenient options for qualitative EBV antibody testing.